Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I like the diversity of topics that MedCity News covers – ranging from devices to policy to start-up companies. Always something interesting to find.”

Robert J. Szczerba, Ph.D., CEO, X Tech Ventures


Sign up for our daily newsletter


Texture of shark’s skin inspires a unique approach to bacteria control for healthcare

11:10 am by | 0 Comments

The insides of these fearsome fish may be harboring drug-resistant bacteria, but apparently, the outsides are doing just the opposite. And now a synthetic surface designed to mimic the bacterial-resistant properties of shark skin is making its way into medical devices and hospitals.

University of Florida researcher Anthony Brennan observed the antimicrobial properties of shark denticles about a decade ago while looking for ways to reduce the buildup of algae on submarines. He created a physical surface with microscopic patterns of ridges that mimicked the patterns found on shark skin, hoping it would inhibit microorganism growth without the use of antimicrobial agents. It’s more efficient to prevent bacteria and algae from growing, he proposed, than to try to kill it.

In the decade since his initial observation, the material has shown effectiveness against the growth and spread of bacteria, led to the formation of a company and is being applied to a variety of industries including healthcare.

Advertisement

In studies, the technology has inhibited the growth of E. coli by 80 percent over control surfaces and has also demonstrated effectiveness against Staphylococcus aureus, MRSA, VRE and Pseudomonas aeruginosa, according to Sharklet Technologies, the Aurora, Colorado company working to commercialize the technology. Those and other bacteria are behind the 1.7 million hospital-acquired infections contracted each year in the U.S.

Sharklet just secured a new $2 million series B capital investment from Altria Ventures, which will take 12.5 percent stake in the company.

With the funding, the company says it will continue to develop the technology for medical devices. It’s already working with Cook Medical to apply its surface technology to Cook’s line of urology products and with LGInternational to commercialize adhesive covers for high-touch surfaces in hospitals.

The emergence of superbugs has driven the development of alternative methods for combating bacteria aside from antibiotics — with new vaccines, surface and device coatings, large-scale sterilization devices and hand-washing compliance technology.

Sharklet is also applying the technology to commercial products and boats.

Previous funding has come from a set of Small Business Innovation Research grants from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases.

[Photo by Parker Knight]

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Deanna Pogorelc

By Deanna Pogorelc MedCity News

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
More posts by Author

0 comments